Search Results 351-360 of 15979 for pharmacogenetics
The Human Genome Project was launched in 1990 to determine the DNA sequence of the entire human genome. Since its completion in 2003, the project has paved ...
Explore a comprehensive list of prescription and over-the-counter medications starting with the letter “G” to learn about drug side effects, proper use and ...
ROCHESTER, Minn. — May 4, 2012. Mayo Clinic and University of Oregon researchers have confirmed that a genetic factor called a repeating trinucleotide is a ...
Understand women's health issues, including leading health risks, menopause, breast health and more.
Pinto E Vairo F, Prochnow C, Kemppainen JL, Lisi EC, Steyermark JM, Kruisselbrink TM, Pichurin PN, Dhamija R, Hager MM, Albadri S, Cornell LD, Lazaridis KN, ...
Results of a Long QT Syndrome study in the current issue of Circulation play an important role in understanding genetic testing's role in diagnosing disease ...
Ponatinib hydrochloride may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. Participation eligibility. Participant ...
Find gastroenterology, hepatology and digestive disease clinical trials at your nearest Mayo Clinic location.
The proposed clinical trial will study the effects of 12 months of therapy with ARN-509 alone, or in combination with an LHRH agonist (LHRHa), each compared to ...
This randomized phase II trial studies how well olaparib, cediranib maleate, and standard chemotherapy work in treating patients with small cell lung cancer.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift to our 2025 Drive to Cure Cancer and transform the way cancer is treated and defeated.